EGCG also inhibited NLRP3 inflammasome activation by reducing NLRP3 expression and production of active caspase-1, IL-1β, and IL-18 in NZB/W F1 lupus-prone mice [86]. Here, IL18 is linked to systemic lupus erythematosus.